BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25337223)

  • 21. c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.
    Li Y; Jin K; van Pelt GW; van Dam H; Yu X; Mesker WE; Ten Dijke P; Zhou F; Zhang L
    Cancer Res; 2016 Jun; 76(11):3364-75. PubMed ID: 27197202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
    Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS
    Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
    Wang X; Lin C; Zhao X; Liu A; Zhu J; Li X; Song L
    Mol Cancer; 2014 May; 13():106. PubMed ID: 24886245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7.
    Li JT; Jia LT; Liu NN; Zhu XS; Liu QQ; Wang XL; Yu F; Liu YL; Yang AG; Gao CF
    Oncotarget; 2015 Oct; 6(31):30818-30. PubMed ID: 26360780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers deposition.
    Zhu X; Zhong J; Zhao Z; Sheng J; Wang J; Liu J; Cui K; Chang J; Zhao H; Wong S
    Oncotarget; 2015 Sep; 6(28):25320-38. PubMed ID: 26318291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
    Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins.
    Cibis H; Biyanee A; Dörner W; Mootz HD; Klempnauer KH
    Sci Rep; 2020 May; 10(1):8390. PubMed ID: 32439918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer.
    Lian B; Li H; Liu Y; Chai D; Gao Y; Zhang Y; Zhou J; Li J
    Breast Cancer; 2021 Mar; 28(2):448-458. PubMed ID: 33108608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate Apoptosis Response-4 (PAR4) Suppresses Growth and Invasion of Breast Cancer Cells and Is Positively Associated with Patient Survival.
    Satherley LK; Sun PH; Ji KE; Mason M; Hargest R; Jiang WG; Ye L
    Anticancer Res; 2016 Mar; 36(3):1227-35. PubMed ID: 26977019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer.
    Xue JQ; Xia TS; Liang XQ; Zhou W; Cheng L; Shi L; Wang Y; Ding Q
    BMC Cancer; 2014 May; 14():322. PubMed ID: 24884756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
    Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP
    Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation.
    Zhang N; Liu L; Fan N; Zhang Q; Wang W; Zheng M; Ma L; Li Y; Shi L
    Oncotarget; 2016 Sep; 7(38):61587-61600. PubMed ID: 27557506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway.
    Lei JJ; Peng RJ; Kuang BH; Yuan ZY; Qin T; Liu WS; Guo YM; Han HQ; Lian YF; Deng CC; Zhang HJ; Chen LZ; Feng QS; Xu M; Feng L; Bei JX; Zeng YX
    Oncotarget; 2015 Sep; 6(28):25701-14. PubMed ID: 26213846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
    Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
    Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-MYB positively regulates serine-threonine kinase receptor-associated protein (STRAP) activity through direct interaction.
    Seong HA; Manoharan R; Ha H
    J Biol Chem; 2011 Mar; 286(9):7439-56. PubMed ID: 21148321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
    Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
    Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers.
    Chou WC; Chen WT; Hsiung CN; Hu LY; Yu JC; Hsu HM; Shen CY
    Sci Rep; 2017 Mar; 7():44089. PubMed ID: 28276478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural mechanism of Myb-MuvB assembly.
    Guiley KZ; Iness AN; Saini S; Tripathi S; Lipsick JS; Litovchick L; Rubin SM
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10016-10021. PubMed ID: 30224471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.